BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2024 4:10:20 AM | Browse: 379 | Download: 1216
 |
Received |
|
2023-10-30 12:45 |
 |
Peer-Review Started |
|
2023-10-30 12:46 |
 |
First Decision by Editorial Office Director |
|
2023-12-05 18:04 |
 |
Return for Revision |
|
2023-12-05 18:04 |
 |
Revised |
|
2023-12-19 15:16 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-01-16 02:44 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-01-16 05:08 |
 |
Articles in Press |
|
2024-01-16 05:08 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-02-18 03:40 |
 |
Publish the Manuscript Online |
|
2024-02-26 04:10 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yun Yuan, Xu-Fan Zhang, Yu-Chen Li, Hong-Qing Chen, Tian Wen, Jia-Lian Zheng, Zi-Yi Zhao and Qiong-Ying Hu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82074298 |
| Chengdu Science and Technology Bureau Project |
2021-YF05-01726-SN |
| “Xinglin Scholars” Research Promotion Program of Chengdu University of Traditional Chinese Medicine |
QJRC2022007 |
|
| Corresponding Author |
Qiong-Ying Hu, MD, PhD, Associate Professor, Department of Laboratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shierqiao Road, Jinniu District, Chengdu 610072, Sichuan Province, China. qiongyinghu@163.com |
| Key Words |
Colorectal cancer stem cells; Stemness; VX-509; Epithelial-mesenchymal transition; Nodal |
| Core Tip |
Colorectal cancer (CRC) is a malignant cancer of the digestive tract with high recurrence and metastasis. CRC stem cells (CCSCs) exerted self-renewing and repopulating capacity, which are hard to eliminate and cause recurrence and metastasis of CRC. VX-509 has been reported as a rheumatoid arthritis regular treatment. However, the role of VX-509 in CCSCs is not well studied. In this study, VX-509 inhibited the malignant biological behaviors and stemness of CCSCs. Further experiments suggested that VX-509 downregulated the expression of Nodal to suppress the epithelial-mesenchymal transition and inhibit the stemness of CCSCs, which provided a potent therapy measure for CRC. |
| Publish Date |
2024-02-26 04:10 |
| Citation |
Yuan Y, Zhang XF, Li YC, Chen HQ, Wen T, Zheng JL, Zhao ZY, Hu QY. VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling. World J Stem Cells 2024; 16(2): 207-227
|
| URL |
https://www.wjgnet.com/1948-0210/full/v16/i2/207.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v16.i2.207 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.